BR0014311A - Quinazolinones - Google Patents
QuinazolinonesInfo
- Publication number
- BR0014311A BR0014311A BR0014311-1A BR0014311A BR0014311A BR 0014311 A BR0014311 A BR 0014311A BR 0014311 A BR0014311 A BR 0014311A BR 0014311 A BR0014311 A BR 0014311A
- Authority
- BR
- Brazil
- Prior art keywords
- quinazolinones
- ibix
- solvates
- salts
- formula
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
- C07D239/88—Oxygen atoms
- C07D239/90—Oxygen atoms with acyclic radicals attached in position 2 or 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
- C07D239/88—Oxygen atoms
- C07D239/91—Oxygen atoms with aryl or aralkyl radicals attached in position 2 or 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Abstract
"QUINAZOLINONAS". A presente invenção refere-se a quinazolinonas de fórmula ( I ) em que R, R^ 1^, R^ 2^, R^ 3^, R^ 4^, Y, n e m têm os significados indicados na reivindicação 1 da patente, e seus sais ou solvatos como antagonistas de glicoproteína IbIx."QUINAZOLINONES". The present invention relates to quinazolinones of formula (I) in which R, R ^ 1 ^, R ^ 2 ^, R ^ 3 ^, R ^ 4 ^, Y, nor have the meanings indicated in patent claim 1, and their salts or solvates as IbIx glycoprotein antagonists.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US40793999A | 1999-09-28 | 1999-09-28 | |
PCT/EP2000/008939 WO2001023364A1 (en) | 1999-09-28 | 2000-09-13 | Quinazolinones |
Publications (1)
Publication Number | Publication Date |
---|---|
BR0014311A true BR0014311A (en) | 2002-05-21 |
Family
ID=23614192
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0014311-1A BR0014311A (en) | 1999-09-28 | 2000-09-13 | Quinazolinones |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP1216233A1 (en) |
KR (1) | KR20020047185A (en) |
AR (1) | AR025796A1 (en) |
AU (1) | AU7419300A (en) |
BR (1) | BR0014311A (en) |
CA (1) | CA2385918A1 (en) |
NO (1) | NO20021503D0 (en) |
WO (1) | WO2001023364A1 (en) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7671200B2 (en) | 1999-10-27 | 2010-03-02 | Cytokinetics, Inc. | Quinazolinone KSP inhibitors |
US7230000B1 (en) | 1999-10-27 | 2007-06-12 | Cytokinetics, Incorporated | Methods and compositions utilizing quinazolinones |
US6545004B1 (en) | 1999-10-27 | 2003-04-08 | Cytokinetics, Inc. | Methods and compositions utilizing quinazolinones |
JP4887139B2 (en) | 2003-03-25 | 2012-02-29 | 武田薬品工業株式会社 | Dipeptidyl peptidase inhibitor |
RU2006107553A (en) | 2003-08-13 | 2007-09-20 | Такеда Фармасьютикал Компани Лимитед (Jp) | 4-Pyrimidone derivatives and their use as peptidyl peptidase inhibitors |
EP1699777B1 (en) | 2003-09-08 | 2012-12-12 | Takeda Pharmaceutical Company Limited | Dipeptidyl peptidase inhibitors |
NZ549716A (en) | 2004-03-15 | 2010-04-30 | Takeda Pharmaceutical | Pyrimidin-dione derivatives as dipeptidyl peptidase inhibitors |
WO2006068978A2 (en) | 2004-12-21 | 2006-06-29 | Takeda Pharmaceutial Company Limited | Dipeptidyl peptidase inhibitors |
NZ566799A (en) | 2005-09-14 | 2011-04-29 | Takeda Pharmaceutical | Dipeptidyl peptidase inhibitors for treating diabetes |
CN101360723A (en) | 2005-09-16 | 2009-02-04 | 武田药品工业株式会社 | Process for the preparation of pyrimidinedione derivatives |
US8324383B2 (en) | 2006-09-13 | 2012-12-04 | Takeda Pharmaceutical Company Limited | Methods of making polymorphs of benzoate salt of 2-[[6-[(3R)-3-amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl]methyl]-benzonitrile |
TW200838536A (en) | 2006-11-29 | 2008-10-01 | Takeda Pharmaceutical | Polymorphs of succinate salt of 2-[6-(3-amino-piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethy]-4-fluor-benzonitrile and methods of use therefor |
US8093236B2 (en) | 2007-03-13 | 2012-01-10 | Takeda Pharmaceuticals Company Limited | Weekly administration of dipeptidyl peptidase inhibitors |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5783577A (en) * | 1995-09-15 | 1998-07-21 | Trega Biosciences, Inc. | Synthesis of quinazolinone libraries and derivatives thereof |
-
2000
- 2000-09-13 CA CA002385918A patent/CA2385918A1/en not_active Abandoned
- 2000-09-13 AU AU74193/00A patent/AU7419300A/en not_active Abandoned
- 2000-09-13 WO PCT/EP2000/008939 patent/WO2001023364A1/en not_active Application Discontinuation
- 2000-09-13 EP EP00962482A patent/EP1216233A1/en not_active Withdrawn
- 2000-09-13 BR BR0014311-1A patent/BR0014311A/en not_active Application Discontinuation
- 2000-09-13 KR KR1020027003906A patent/KR20020047185A/en not_active Application Discontinuation
- 2000-09-27 AR ARP000105075A patent/AR025796A1/en unknown
-
2002
- 2002-03-26 NO NO20021503A patent/NO20021503D0/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
AR025796A1 (en) | 2002-12-11 |
WO2001023364A1 (en) | 2001-04-05 |
EP1216233A1 (en) | 2002-06-26 |
CA2385918A1 (en) | 2001-04-05 |
NO20021503L (en) | 2002-03-26 |
KR20020047185A (en) | 2002-06-21 |
AU7419300A (en) | 2001-04-30 |
NO20021503D0 (en) | 2002-03-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR0114020A (en) | 4-amino-quinazolines | |
BR0007527A (en) | Phenylphenanthridines with IV-dependent inhibitory activity | |
BR0014311A (en) | Quinazolinones | |
BR9815518A (en) | Antibacterial oxazolidinone agents having thiocarbonyl functionality | |
BR0211521A (en) | Retinoid derivatives with antiangiogenic, antitumor and pro-apoptotic activities | |
BRPI0410995A (en) | n-alkynyl-2- (substituted aryloxy) alkylthioamide derivatives as fungicides | |
BR9800884A (en) | Application of pyrimidine derivatives for cancer prevention, alone or in combination with other therapeutic measures. | |
BR0313732A (en) | Pyrimide compounds having antiproliferative activity | |
BR9916111A (en) | Phenylglycine derivatives | |
DE69716135T2 (en) | IN 6-POSITION BY THIO SUBSTITUTED PACLITAXELE | |
BR0209440A (en) | Sulfonamides | |
BRPI0409164A (en) | substituted pyrazoles | |
BR0205889A (en) | Pyrazolopyrimidines as tepapia agents | |
BR0313676A (en) | Pyrimidine derivatives and their use as cb2 modulators | |
BR9912299A (en) | Biphenyl derivatives | |
BR9803704A (en) | Quinazoline-4-one as ampa antagonists. | |
BR0212069A (en) | Oral antidiabetic agents | |
BR9916680A (en) | Derivatives of 3,3-biarylpiperidine and 2,2-biarylmorpholine | |
BR0114021A (en) | 4-amino-quinazolines | |
BR0215016A (en) | Antiviral Pyridoquinoxalines | |
BR9915611A (en) | Benzo [de] substituted isoquinoline-1,3-diones | |
BR0211995A (en) | Combination preparations of aryl substituted propanolamine derivatives with other active substances and their application | |
BR0213037A (en) | Pyrimidine Derivatives | |
BR9801132A (en) | Fused N-heterocycles, substituted with benzyloxy, process for their preparation and use as bradykinin receptor antagonists. | |
BR9915648A (en) | Benzo [de] substituted isoquinoline-1,3-diones |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B11A | Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing | ||
B11Y | Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette] |